Literature DB >> 24740535

Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis.

Christina E Barkauskas1, Paul W Noble2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by severe and progressive scar formation in the gas-exchange regions of the lung. Despite years of research, therapeutic treatments remain elusive and there is a pressing need for deeper mechanistic insights into the pathogenesis of the disease. In this article, we review our current knowledge of the triggers and/or perpetuators of pulmonary fibrosis with special emphasis on the alveolar epithelium and the underlying mesenchyme. In doing so, we raise a number of questions highlighting critical voids and limitations in our current understanding and study of this disease.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  epithelium; lung fibrosis; myofibroblast

Mesh:

Year:  2014        PMID: 24740535      PMCID: PMC4422352          DOI: 10.1152/ajpcell.00321.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  93 in total

1.  Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.

Authors:  Shuei-Liong Lin; Fan-Chi Chang; Claudia Schrimpf; Yi-Ting Chen; Ching-Fang Wu; Vin-Cent Wu; Wen-Chih Chiang; Frank Kuhnert; Calvin J Kuo; Yung-Ming Chen; Kwan-Dun Wu; Tun-Jun Tsai; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs.

Authors:  William E Lawson; Dong-Sheng Cheng; Amber L Degryse; Harikrishna Tanjore; Vasiliy V Polosukhin; Xiaochuan C Xu; Dawn C Newcomb; Brittany R Jones; Juan Roldan; Kirk B Lane; Edward E Morrisey; Michael F Beers; Fiona E Yull; Timothy S Blackwell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

3.  Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Authors:  Paul W Noble; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Marilyn K Glassberg; David Kardatzke; Talmadge E King; Lisa Lancaster; Steven A Sahn; Javier Szwarcberg; Dominique Valeyre; Roland M du Bois
Journal:  Lancet       Date:  2011-05-13       Impact factor: 79.321

4.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.

Authors:  Jason R Rock; Christina E Barkauskas; Michael J Cronce; Yan Xue; Jeffrey R Harris; Jiurong Liang; Paul W Noble; Brigid L M Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC.

Authors:  Peter F Crossno; Vasiliy V Polosukhin; Timothy S Blackwell; Joyce E Johnson; Cheryl Markin; Paul E Moore; John A Worrell; Mildred T Stahlman; John A Phillips; James E Loyd; Joy D Cogan; William E Lawson
Journal:  Chest       Date:  2010-04       Impact factor: 9.410

6.  Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.

Authors:  Amber L Degryse; Harikrishna Tanjore; Xiaochuan C Xu; Vasiliy V Polosukhin; Brittany R Jones; Frank B McMahon; Linda A Gleaves; Timothy S Blackwell; William E Lawson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-18       Impact factor: 5.464

7.  A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis.

Authors:  Yingze Zhang; Imre Noth; Joe G N Garcia; Naftali Kaminski
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

8.  A common MUC5B promoter polymorphism and pulmonary fibrosis.

Authors:  Max A Seibold; Anastasia L Wise; Marcy C Speer; Mark P Steele; Kevin K Brown; James E Loyd; Tasha E Fingerlin; Weiming Zhang; Gunnar Gudmundsson; Steve D Groshong; Christopher M Evans; Stavros Garantziotis; Kenneth B Adler; Burton F Dickey; Roland M du Bois; Ivana V Yang; Aretha Herron; Dolly Kervitsky; Janet L Talbert; Cheryl Markin; Joungjoa Park; Anne L Crews; Susan H Slifer; Scott Auerbach; Michelle G Roy; Jia Lin; Corinne E Hennessy; Marvin I Schwarz; David A Schwartz
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

9.  Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Ulrich Costabel; Moises Selman; Dong Soon Kim; David M Hansell; Andrew G Nicholson; Kevin K Brown; Kevin R Flaherty; Paul W Noble; Ganesh Raghu; Michèle Brun; Abhya Gupta; Nolwenn Juhel; Matthias Klüglich; Roland M du Bois
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

10.  Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.

Authors:  Yuejuan Li; Dianhua Jiang; Jiurong Liang; Eric B Meltzer; Alice Gray; Riu Miura; Lise Wogensen; Yu Yamaguchi; Paul W Noble
Journal:  J Exp Med       Date:  2011-06-27       Impact factor: 14.307

View more
  62 in total

1.  TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.

Authors:  Shaik O Rahaman; Lisa M Grove; Sailaja Paruchuri; Brian D Southern; Susamma Abraham; Kathryn A Niese; Rachel G Scheraga; Sudakshina Ghosh; Charles K Thodeti; David X Zhang; Magdalene M Moran; William P Schilling; Daniel J Tschumperlin; Mitchell A Olman
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Authors:  Vishwaraj Sontake; Shiva K Shanmukhappa; Betsy A DiPasquale; Geereddy B Reddy; Mario Medvedovic; William D Hardie; Eric S White; Satish K Madala
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

Review 3.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

4.  miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Authors:  Marta Fierro-Fernández; Óscar Busnadiego; Pilar Sandoval; Cristina Espinosa-Díez; Eva Blanco-Ruiz; Macarena Rodríguez; Héctor Pian; Ricardo Ramos; Manuel López-Cabrera; Maria Laura García-Bermejo; Santiago Lamas
Journal:  EMBO Rep       Date:  2015-08-27       Impact factor: 8.807

Review 5.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

6.  miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.

Authors:  Huachun Cui; Jing Ge; Na Xie; Sami Banerjee; Yong Zhou; Veena B Antony; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

7.  Single cell RNA sequencing identifies TGFβ as a key regenerative cue following LPS-induced lung injury.

Authors:  Kent A Riemondy; Nicole L Jansing; Peng Jiang; Elizabeth F Redente; Austin E Gillen; Rui Fu; Alyssa J Miller; Jason R Spence; Anthony N Gerber; Jay R Hesselberth; Rachel L Zemans
Journal:  JCI Insight       Date:  2019-03-26

Review 8.  When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine.

Authors:  Michael F Beers; Yuben Moodley
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

9.  miR-200b/c attenuates lipopolysaccharide-induced early pulmonary fibrosis by targeting ZEB1/2 via p38 MAPK and TGF-β/smad3 signaling pathways.

Authors:  Yongmei Cao; Yujing Liu; Feng Ping; Lyu Yi; Zhen Zeng; Yingchuan Li
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

10.  Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.

Authors:  Yan Xu; Takako Mizuno; Anusha Sridharan; Yina Du; Minzhe Guo; Jie Tang; Kathryn A Wikenheiser-Brokamp; Anne-Karina T Perl; Vincent A Funari; Jason J Gokey; Barry R Stripp; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.